10-QPeriod: Q1 FY2021

UNITEDHEALTH GROUP INC Quarterly Report for Q1 Ended Mar 31, 2021

Filed May 5, 2021For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) reported strong financial performance for the first quarter of 2021, with total revenues increasing by 9% year-over-year to $70.2 billion. This growth was driven by robust performance across both its UnitedHealthcare and Optum segments. UnitedHealthcare saw an 8% revenue increase, bolstered by growth in Medicare Advantage and Medicaid enrollment, despite a decline in commercial business. The Optum segment demonstrated significant strength, with total revenues up 11%, driven by substantial growth in OptumHealth and OptumInsight. Net earnings attributable to common shareholders surged by 44% to $4.9 billion, translating to a 44% increase in diluted earnings per share to $5.08. This improved profitability was supported by a lower effective tax rate due to the repeal of the Health Insurance Tax, coupled with strong operational performance and careful cost management. The company also highlighted its ongoing commitment to shareholder returns through share repurchases and dividends. Management expressed confidence in the company's liquidity and ability to meet future obligations, with significant cash reserves and strong credit ratings.

Financial Highlights

54 data points
Beta

Revenue

$70.20B

89.2% Gross Margin

Net Income

$4.86B

6.9% Net Margin

EPS (Diluted)

$5.08

Total Assets

$205.17B

Cash & Equivalents

$19.95B

Free Cash Flow

$5.44B

Financial Statements
Beta
Revenue$70.20B
Cost of Revenue$7.57B
Gross Profit$62.62B
SG&A Expenses$10.22B
Operating Expenses$63.46B
Operating Income$6.74B
Interest Expense$397.00M
Net Income$4.86B
EPS (Basic)$5.14
EPS (Diluted)$5.08
Shares Outstanding (Basic)945.00M
Shares Outstanding (Diluted)957.00M

Key Highlights

  • 1Total revenues increased by 9% to $70.2 billion, driven by growth in both UnitedHealthcare and Optum segments.
  • 2Net earnings attributable to common shareholders rose 44% to $4.9 billion.
  • 3Diluted earnings per share (EPS) increased by 44% to $5.08.
  • 4UnitedHealthcare served 1.1 million more people domestically, with significant growth in Medicare Advantage and Medicaid.
  • 5Optum segment revenues grew 11%, with OptumHealth and OptumInsight showing strong performance.
  • 6Cash flows from operating activities were robust at $6.0 billion for the quarter.
  • 7The company is proceeding with the acquisition of Change Healthcare, expected to close in the second half of 2021, subject to regulatory approvals.

Frequently Asked Questions

COVID-19 had a mixed impact. While temporary deferrals of elective care initially reduced utilization, this was offset by increased COVID-19 related care and testing costs. The company also saw declines in its commercial benefits business due to economic impacts like unemployment. However, the repeal of the Health Insurance Tax provided a significant benefit to profitability.

Growth in UnitedHealthcare was primarily driven by an increase in the number of individuals served through Medicare Advantage and Medicaid programs. This growth was partially offset by a decrease in individuals served by the commercial benefits business due to economic conditions related to COVID-19.

The company maintains strong liquidity with substantial cash and cash equivalents, as well as available-for-sale securities. Its debt-to-debt-plus-shareholders' equity ratio was approximately 39% as of March 31, 2021, well within its debt covenant limit of 60%. UNH also has significant revolving credit facilities available and continues to manage its debt and capital resources effectively, with strong credit ratings from major agencies.

A major ongoing initiative is the acquisition of Change Healthcare, expected to close in the second half of 2021, subject to regulatory approvals. The company also continues to focus on growing its Optum and UnitedHealthcare businesses, enhancing care delivery models, and leveraging technology to improve health outcomes and manage costs.